Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism

NCT02944110 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT02944110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02944110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2016
Completion date
July 31, 2021
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes after total pancreatectomy